This activates the toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) signaling pathway and causes an inflammatory response in the liver, and inhibition of the inflammatory response by regulating the bacterial groups effectively improved NAFLD and NASH (16). The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.